2018-2023 Global Platinum based Cancer Drug Consumption Market Report

October 2018 | 164 pages | ID: 2BBFA8054E2EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Platinum based Cancer Drug market for 2018-2023.
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Asia-Pacific is the largest sales place, with a sales market share nearly 42% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 20%.

Over the next five years, LPI(LP Information) projects that Platinum based Cancer Drug will register a 3.5% CAGR in terms of revenue, reach US$ 1580 million by 2023, from US$ 1290 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Platinum based Cancer Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Cisplatin
• Oxaliplatin
• Carboplatin
• Other

Segmentation by application:

• Colorectal Cancer
• Ovarian Cancer
• Lung Cancer
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Sanofi
• Hengrui Medicine
• ASK Pharma
• Yi Bai Pharmaceutical
• Qilu Pharmaceutical
• Teva
• Pfizer
• Dr Reddy's Laboratories
• Mylan
• Sun Pharma
• Novartis
• Debiopharm
• Accord Healthcare
• SK Chemicals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Platinum based Cancer Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Platinum based Cancer Drug market by identifying its various subsegments.
• Focuses on the key global Platinum based Cancer Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Platinum based Cancer Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Platinum based Cancer Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL PLATINUM BASED CANCER DRUG CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Platinum based Cancer Drug Consumption 2013-2023
  2.1.2 Platinum based Cancer Drug Consumption CAGR by Region
2.2 Platinum based Cancer Drug Segment by Type
  2.2.1 Cisplatin
  2.2.2 Oxaliplatin
  2.2.3 Carboplatin
  2.2.4 Other
2.3 Platinum based Cancer Drug Consumption by Type
  2.3.1 Global Platinum based Cancer Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Platinum based Cancer Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Platinum based Cancer Drug Sale Price by Type (2013-2018)
2.4 Platinum based Cancer Drug Segment by Application
  2.4.1 Colorectal Cancer
  2.4.2 Ovarian Cancer
  2.4.3 Lung Cancer
  2.4.4 Other
2.5 Platinum based Cancer Drug Consumption by Application
  2.5.1 Global Platinum based Cancer Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Platinum based Cancer Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Platinum based Cancer Drug Sale Price by Application (2013-2018)

3 GLOBAL PLATINUM BASED CANCER DRUG BY PLAYERS

3.1 Global Platinum based Cancer Drug Sales Market Share by Players
  3.1.1 Global Platinum based Cancer Drug Sales by Players (2016-2018)
  3.1.2 Global Platinum based Cancer Drug Sales Market Share by Players (2016-2018)
3.2 Global Platinum based Cancer Drug Revenue Market Share by Players
  3.2.1 Global Platinum based Cancer Drug Revenue by Players (2016-2018)
  3.2.2 Global Platinum based Cancer Drug Revenue Market Share by Players (2016-2018)
3.3 Global Platinum based Cancer Drug Sale Price by Players
3.4 Global Platinum based Cancer Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Platinum based Cancer Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Platinum based Cancer Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PLATINUM BASED CANCER DRUG BY REGIONS

4.1 Platinum based Cancer Drug by Regions
  4.1.1 Global Platinum based Cancer Drug Consumption by Regions
  4.1.2 Global Platinum based Cancer Drug Value by Regions
4.2 Americas Platinum based Cancer Drug Consumption Growth
4.3 APAC Platinum based Cancer Drug Consumption Growth
4.4 Europe Platinum based Cancer Drug Consumption Growth
4.5 Middle East & Africa Platinum based Cancer Drug Consumption Growth

5 AMERICAS

5.1 Americas Platinum based Cancer Drug Consumption by Countries
  5.1.1 Americas Platinum based Cancer Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Platinum based Cancer Drug Value by Countries (2013-2018)
5.2 Americas Platinum based Cancer Drug Consumption by Type
5.3 Americas Platinum based Cancer Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Platinum based Cancer Drug Consumption by Countries
  6.1.1 APAC Platinum based Cancer Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Platinum based Cancer Drug Value by Countries (2013-2018)
6.2 APAC Platinum based Cancer Drug Consumption by Type
6.3 APAC Platinum based Cancer Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Platinum based Cancer Drug by Countries
  7.1.1 Europe Platinum based Cancer Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Platinum based Cancer Drug Value by Countries (2013-2018)
7.2 Europe Platinum based Cancer Drug Consumption by Type
7.3 Europe Platinum based Cancer Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Platinum based Cancer Drug by Countries
  8.1.1 Middle East & Africa Platinum based Cancer Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Platinum based Cancer Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Platinum based Cancer Drug Consumption by Type
8.3 Middle East & Africa Platinum based Cancer Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Platinum based Cancer Drug Distributors
10.3 Platinum based Cancer Drug Customer

11 GLOBAL PLATINUM BASED CANCER DRUG MARKET FORECAST

11.1 Global Platinum based Cancer Drug Consumption Forecast (2018-2023)
11.2 Global Platinum based Cancer Drug Forecast by Regions
  11.2.1 Global Platinum based Cancer Drug Forecast by Regions (2018-2023)
  11.2.2 Global Platinum based Cancer Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Platinum based Cancer Drug Forecast by Type
11.8 Global Platinum based Cancer Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Sanofi
  12.1.1 Company Details
  12.1.2 Platinum based Cancer Drug Product Offered
  12.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Sanofi News
12.2 Hengrui Medicine
  12.2.1 Company Details
  12.2.2 Platinum based Cancer Drug Product Offered
  12.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Hengrui Medicine News
12.3 ASK Pharma
  12.3.1 Company Details
  12.3.2 Platinum based Cancer Drug Product Offered
  12.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 ASK Pharma News
12.4 Yi Bai Pharmaceutical
  12.4.1 Company Details
  12.4.2 Platinum based Cancer Drug Product Offered
  12.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Yi Bai Pharmaceutical News
12.5 Qilu Pharmaceutical
  12.5.1 Company Details
  12.5.2 Platinum based Cancer Drug Product Offered
  12.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Qilu Pharmaceutical News
12.6 Teva
  12.6.1 Company Details
  12.6.2 Platinum based Cancer Drug Product Offered
  12.6.3 Teva Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Teva News
12.7 Pfizer
  12.7.1 Company Details
  12.7.2 Platinum based Cancer Drug Product Offered
  12.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Pfizer News
12.8 Dr Reddy's Laboratories
  12.8.1 Company Details
  12.8.2 Platinum based Cancer Drug Product Offered
  12.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Dr Reddy's Laboratories News
12.9 Mylan
  12.9.1 Company Details
  12.9.2 Platinum based Cancer Drug Product Offered
  12.9.3 Mylan Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Mylan News
12.10 Sun Pharma
  12.10.1 Company Details
  12.10.2 Platinum based Cancer Drug Product Offered
  12.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Sun Pharma News
12.11 Novartis
12.12 Debiopharm
12.13 Accord Healthcare
12.14 SK Chemicals

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Platinum based Cancer Drug
Table Product Specifications of Platinum based Cancer Drug
Figure Platinum based Cancer Drug Report Years Considered
Figure Market Research Methodology
Figure Global Platinum based Cancer Drug Consumption Growth Rate 2013-2023 (K Units)
Figure Global Platinum based Cancer Drug Value Growth Rate 2013-2023 ($ Millions)
Table Platinum based Cancer Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Cisplatin
Table Major Players of Cisplatin
Figure Product Picture of Oxaliplatin
Table Major Players of Oxaliplatin
Figure Product Picture of Carboplatin
Table Major Players of Carboplatin
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Platinum based Cancer Drug Consumption Market Share by Type (2013-2018)
Figure Global Platinum based Cancer Drug Consumption Market Share by Type (2013-2018)
Table Global Platinum based Cancer Drug Revenue by Type (2013-2018) ($ million)
Table Global Platinum based Cancer Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Platinum based Cancer Drug Value Market Share by Type (2013-2018)
Table Global Platinum based Cancer Drug Sale Price by Type (2013-2018)
Figure Platinum based Cancer Drug Consumed in Colorectal Cancer
Figure Global Platinum based Cancer Drug Market: Colorectal Cancer (2013-2018) (K Units)
Figure Global Platinum based Cancer Drug Market: Colorectal Cancer (2013-2018) ($ Millions)
Figure Global Colorectal Cancer YoY Growth ($ Millions)
Figure Platinum based Cancer Drug Consumed in Ovarian Cancer
Figure Global Platinum based Cancer Drug Market: Ovarian Cancer (2013-2018) (K Units)
Figure Global Platinum based Cancer Drug Market: Ovarian Cancer (2013-2018) ($ Millions)
Figure Global Ovarian Cancer YoY Growth ($ Millions)
Figure Platinum based Cancer Drug Consumed in Lung Cancer
Figure Global Platinum based Cancer Drug Market: Lung Cancer (2013-2018) (K Units)
Figure Global Platinum based Cancer Drug Market: Lung Cancer (2013-2018) ($ Millions)
Figure Global Lung Cancer YoY Growth ($ Millions)
Figure Platinum based Cancer Drug Consumed in Other
Figure Global Platinum based Cancer Drug Market: Other (2013-2018) (K Units)
Figure Global Platinum based Cancer Drug Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Platinum based Cancer Drug Consumption Market Share by Application (2013-2018)
Figure Global Platinum based Cancer Drug Consumption Market Share by Application (2013-2018)
Table Global Platinum based Cancer Drug Value by Application (2013-2018)
Table Global Platinum based Cancer Drug Value Market Share by Application (2013-2018)
Figure Global Platinum based Cancer Drug Value Market Share by Application (2013-2018)
Table Global Platinum based Cancer Drug Sale Price by Application (2013-2018)
Table Global Platinum based Cancer Drug Sales by Players (2016-2018) (K Units)
Table Global Platinum based Cancer Drug Sales Market Share by Players (2016-2018)
Figure Global Platinum based Cancer Drug Sales Market Share by Players in 2016
Figure Global Platinum based Cancer Drug Sales Market Share by Players in 2017
Table Global Platinum based Cancer Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Platinum based Cancer Drug Revenue Market Share by Players (2016-2018)
Figure Global Platinum based Cancer Drug Revenue Market Share by Players in 2016
Figure Global Platinum based Cancer Drug Revenue Market Share by Players in 2017
Table Global Platinum based Cancer Drug Sale Price by Players (2016-2018)
Figure Global Platinum based Cancer Drug Sale Price by Players in 2017
Table Global Platinum based Cancer Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Platinum based Cancer Drug Products Offered
Table Platinum based Cancer Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Platinum based Cancer Drug Consumption by Regions 2013-2018 (K Units)
Table Global Platinum based Cancer Drug Consumption Market Share by Regions 2013-2018
Figure Global Platinum based Cancer Drug Consumption Market Share by Regions 2013-2018
Table Global Platinum based Cancer Drug Value by Regions 2013-2018 ($ Millions)
Table Global Platinum based Cancer Drug Value Market Share by Regions 2013-2018
Figure Global Platinum based Cancer Drug Value Market Share by Regions 2013-2018
Figure Americas Platinum based Cancer Drug Consumption 2013-2018 (K Units)
Figure Americas Platinum based Cancer Drug Value 2013-2018 ($ Millions)
Figure APAC Platinum based Cancer Drug Consumption 2013-2018 (K Units)
Figure APAC Platinum based Cancer Drug Value 2013-2018 ($ Millions)
Figure Europe Platinum based Cancer Drug Consumption 2013-2018 (K Units)
Figure Europe Platinum based Cancer Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Platinum based Cancer Drug Consumption 2013-2018 (K Units)
Figure Middle East & Africa Platinum based Cancer Drug Value 2013-2018 ($ Millions)
Table Americas Platinum based Cancer Drug Consumption by Countries (2013-2018) (K Units)
Table Americas Platinum based Cancer Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Platinum based Cancer Drug Consumption Market Share by Countries in 2017
Table Americas Platinum based Cancer Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Platinum based Cancer Drug Value Market Share by Countries (2013-2018)
Figure Americas Platinum based Cancer Drug Value Market Share by Countries in 2017
Table Americas Platinum based Cancer Drug Consumption by Type (2013-2018) (K Units)
Table Americas Platinum based Cancer Drug Consumption Market Share by Type (2013-2018)
Figure Americas Platinum based Cancer Drug Consumption Market Share by Type in 2017
Table Americas Platinum based Cancer Drug Consumption by Application (2013-2018) (K Units)
Table Americas Platinum based Cancer Drug Consumption Market Share by Application (2013-2018)
Figure Americas Platinum based Cancer Drug Consumption Market Share by Application in 2017
Figure United States Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure United States Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Canada Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Mexico Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Table APAC Platinum based Cancer Drug Consumption by Countries (2013-2018) (K Units)
Table APAC Platinum based Cancer Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Platinum based Cancer Drug Consumption Market Share by Countries in 2017
Table APAC Platinum based Cancer Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Platinum based Cancer Drug Value Market Share by Countries (2013-2018)
Figure APAC Platinum based Cancer Drug Value Market Share by Countries in 2017
Table APAC Platinum based Cancer Drug Consumption by Type (2013-2018) (K Units)
Table APAC Platinum based Cancer Drug Consumption Market Share by Type (2013-2018)
Figure APAC Platinum based Cancer Drug Consumption Market Share by Type in 2017
Table APAC Platinum based Cancer Drug Consumption by Application (2013-2018) (K Units)
Table APAC Platinum based Cancer Drug Consumption Market Share by Application (2013-2018)
Figure APAC Platinum based Cancer Drug Consumption Market Share by Application in 2017
Figure China Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure China Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Japan Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Korea Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure India Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure India Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Australia Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Table Europe Platinum based Cancer Drug Consumption by Countries (2013-2018) (K Units)
Table Europe Platinum based Cancer Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Platinum based Cancer Drug Consumption Market Share by Countries in 2017
Table Europe Platinum based Cancer Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Platinum based Cancer Drug Value Market Share by Countries (2013-2018)
Figure Europe Platinum based Cancer Drug Value Market Share by Countries in 2017
Table Europe Platinum based Cancer Drug Consumption by Type (2013-2018) (K Units)
Table Europe Platinum based Cancer Drug Consumption Market Share by Type (2013-2018)
Figure Europe Platinum based Cancer Drug Consumption Market Share by Type in 2017
Table Europe Platinum based Cancer Drug Consumption by Application (2013-2018) (K Units)
Table Europe Platinum based Cancer Drug Consumption Market Share by Application (2013-2018)
Figure Europe Platinum based Cancer Drug Consumption Market Share by Application in 2017
Figure Germany Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Germany Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure France Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure France Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure UK Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure UK Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Italy Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Russia Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Spain Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Platinum based Cancer Drug Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Platinum based Cancer Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Platinum based Cancer Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Platinum based Cancer Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Platinum based Cancer Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Platinum based Cancer Drug Value Market Share by Countries in 2017
Table Middle East & Africa Platinum based Cancer Drug Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Platinum based Cancer Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Platinum based Cancer Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Platinum based Cancer Drug Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Platinum based Cancer Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Platinum based Cancer Drug Consumption Market Share by Application in 2017
Figure Egypt Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Egypt Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure South Africa Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Israel Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure Turkey Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Platinum based Cancer Drug Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Platinum based Cancer Drug Value Growth 2013-2018 ($ Millions)
Table Platinum based Cancer Drug Distributors List
Table Platinum based Cancer Drug Customer List
Figure Global Platinum based Cancer Drug Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Platinum based Cancer Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Platinum based Cancer Drug Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Platinum based Cancer Drug Consumption Market Forecast by Regions
Table Global Platinum based Cancer Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Platinum based Cancer Drug Value Market Share Forecast by Regions
Figure Americas Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Americas Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure APAC Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure APAC Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Europe Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Europe Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Middle East & Africa Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure United States Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure United States Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Canada Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Canada Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Mexico Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Mexico Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Brazil Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Brazil Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure China Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure China Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Japan Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Japan Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Korea Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Korea Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Southeast Asia Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure India Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure India Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Australia Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Australia Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Germany Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Germany Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure France Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure France Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure UK Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure UK Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Italy Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Italy Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Russia Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Russia Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Spain Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Spain Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Egypt Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Egypt Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure South Africa Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure South Africa Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Israel Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Israel Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure Turkey Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure Turkey Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Platinum based Cancer Drug Consumption 2018-2023 (K Units)
Figure GCC Countries Platinum based Cancer Drug Value 2018-2023 ($ Millions)
Table Global Platinum based Cancer Drug Consumption Forecast by Type (2018-2023) (K Units)
Table Global Platinum based Cancer Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Platinum based Cancer Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Platinum based Cancer Drug Value Market Share Forecast by Type (2018-2023)
Table Global Platinum based Cancer Drug Consumption Forecast by Application (2018-2023) (K Units)
Table Global Platinum based Cancer Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Platinum based Cancer Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Platinum based Cancer Drug Value Market Share Forecast by Application (2018-2023)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Platinum based Cancer Drug Market Share (2016-2018)
Table Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hengrui Medicine Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hengrui Medicine Platinum based Cancer Drug Market Share (2016-2018)
Table ASK Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ASK Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ASK Pharma Platinum based Cancer Drug Market Share (2016-2018)
Table Yi Bai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Yi Bai Pharmaceutical Platinum based Cancer Drug Market Share (2016-2018)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Qilu Pharmaceutical Platinum based Cancer Drug Market Share (2016-2018)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Platinum based Cancer Drug Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Platinum based Cancer Drug Market Share (2016-2018)
Table Dr Reddy's Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Dr Reddy's Laboratories Platinum based Cancer Drug Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Platinum based Cancer Drug Market Share (2016-2018)
Table Sun Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharma Platinum based Cancer Drug Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Debiopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Accord Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SK Chemicals Basic Information, Manufacturing Base, Sales Area and Its Competitors